Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 102 of the 106 references it cites were found in a registry or an index; 7 of the 57 sources its claims cite were checked for support.

In Vivo versus Augmented Reality Exposure in the Treatment of Small Animal Phobia: A Randomized Controlled Trial

Open access

Abstract

Although in vivo exposure is the treatment of choice for specific phobias, some acceptability problems have been associated with it. Virtual Reality exposure has been shown to be as effective as in vivo exposure, and it is widely accepted for the treatment of specific phobias, but only preliminary data are available in the literature about the efficacy of Augmented Reality. The purpose of the present study was to examine the efficacy and acceptance of two treatment conditions for specific phobias in which the exposure component was applied in different ways: In vivo exposure (N = 31) versus an Augmented Reality system (N = 32) in a randomized controlled trial. "One-session treatment" guidelines were followed. Participants in the Augmented Reality condition significantly improved on all the outcome measures at post-treatment and follow-ups. When the two treatment conditions were compared, some differences were found at post-treatment, favoring the participants who received in vivo exposure. However, these differences disappeared at the 3- and 6-month follow-ups. Regarding participants' expectations and satisfaction with the treatment, very positive ratings were reported in both conditions. In addition, participants from in vivo exposure condition considered the treatment more useful for their problem whereas participants from Augmented Reality exposure considered the treatment less aversive. Results obtained in this study indicate that Augmented Reality exposure is an effective treatment for specific phobias and well accepted by the participants. © 2016 Botella et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Overview

CoChat Summary

## TL;DR

This randomized controlled trial compared one-session in vivo exposure with augmented reality exposure for small animal phobia (cockroaches/spiders) in 63 adults. Both treatments produced large, sustained improvements through 6 months; in vivo had some post-treatment advantages, but these differences did not persist.

## Key findings

  • 63 participants were randomized: 31 to in vivo exposure (IVE) and 32 to augmented reality exposure (ARE); the sample was 93.7% women, and 85.7% had cockroach phobia.
  • In the intention-to-treat analysis, there was a significant time effect on all BAT measures: Fear-BAT (F3, 61 = 58.73, p < .000), Avoidance-BAT (F3, 61 = 65.59, p < .000), Belief-BAT (F3, 61 = 86.71, p < .000), Performance-BAT (F3, 61 = 209.61, p < .000), maximum anxiety-BAT (F3, 61 = 45.49, p < .000), and clinician-rated Severity-BAT (F3, 60 = 89.14, p < .000).
  • The only BAT variable with a significant between-group interaction in ITT was Avoidance-BAT (F3, 61 = 65.59, p < .020), favoring IVE at post-treatment; this difference was not present at 3- or 6-month follow-ups. In the completer analysis, a similar post-treatment advantage favored IVE on Fear-BAT (F3, 45 = 3.42, p < .029), again disappearing at follow-up.
  • The paper reports that all measures reached Cohen’s d > 0.8 in both conditions at post-treatment and follow-ups; the authors also state that 22/31 (71.0%) in IVE and 18/32 (56.3%) in ARE were diagnosis-free at post-treatment, rising to 24/31 (77.4%) and 22/32 (68.8%) at 3 months, and 20/31 (64.5%) and 20/32 (62.5%) at 6 months.

## Methods

  • Design: Randomized controlled trial with two conditions: in vivo exposure (IVE) and augmented reality exposure (ARE), following one-session treatment guidelines; assessments occurred at pre-treatment, post-treatment, 3 months, and 6 months.
  • Sample/data: Adults 18+ with DSM-IV-TR specific phobia, animal subtype (cockroaches or spiders), recruited via university mailing lists, campus announcements, and local media; 63 participants were included after eligibility screening.
  • Analysis: Between-group baseline comparisons used chi-square tests and t tests; treatment effects were analyzed with repeated-measures ANOVAs in both intention-to-treat (LOCF) and completer analyses; Cohen’s d was calculated, and chi-square tests assessed clinically significant improvement.

## Limitations

  • The paper states there was no waiting list control group, because the authors chose to compare AR with the strongest current treatment, in vivo exposure.
  • The authors state the sample size did not allow equivalence testing, so they could not conclude the two treatments were equally efficacious.
  • The study was conducted in a research context, so the paper states that no data about clinical settings or clinicians’ acceptance were obtained; it also notes no diagnostic interrater reliability was applied because assessors were not always independent from therapists.
  • Evident from the text: the sample was small and heavily female (93.7%), and outcomes were limited to adults with cockroach or spider phobia, which constrains generalization.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0148237

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig 1 Use of the AR system during the exposure session (simulation). (a) virtual cockroaches; (b) virtual spiders.
Fig 1 Use of the AR system during the exposure session (simulation). (a) virtual cockroaches; (b) virtual spiders.CC BY · PubMed Central
Fig 2 Types of spiders available into the AR system.
Fig 2 Types of spiders available into the AR system.CC BY · PubMed Central
Fig 3 A participant interacting with the virtual cockroaches in her hands.
Fig 3 A participant interacting with the virtual cockroaches in her hands.CC BY · PubMed Central
Fig 4 A participant exposed to real cockroaches.
Fig 4 A participant exposed to real cockroaches.CC BY · PubMed Central
Fig 5 Flow diagram of study participants, point of random assignment, and dropouts in each stage of the study.
Fig 5 Flow diagram of study participants, point of random assignment, and dropouts in each stage of the study.CC BY · PubMed Central
Fig 6 Evolution of the measures related with the primary outcome measure (the BAT) in both treatment conditions.
Fig 6 Evolution of the measures related with the primary outcome measure (the BAT) in both treatment conditions.CC BY · PubMed Central

Verification

Claims the paper makes

5 Valid · 0 Not valid · 22 Not checked · 52 Own results and interpretations

27 more claims

Create a free account to see all 79 claims and to verify the 3 references still open.

See all claims — free account
  • Probably not a substantial claim. 28
  • It may state two separate claims as one. 34
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

1 of 1

Citations

Cites

Show all 106 references

Research works printed but not linked: 3

  1. S Quero, 2014, ICERI2014: Proceedings of the 7th International Technology, Education, and Development Conference; 2014 nov 17–19, 1568
  2. Nebot S, Quero S, Bretón-López J, Pérez-Ara MA, Botella C. Validación Española del Cuestionario de Miedo a las Arañas (FSQ) adaptado para la Fobia a las Cucarachas. SEAS2012: Poster presentation at the IX International Conference of the Sociedad Española para el estudio de la Ansiedad y Estrés; 2012 Sep 6–8; Valencia, Spain.
  3. S Corbett-Davies, 2012, Proceeding of the 11th IEEE International Symposium on Mixed and Augmented Reality (ISMAR)

Cited by

See all 125

Metadata

Authors
Botella, C., Pérez-Ara, M. Á., Bretón-López, J., Quero, S., García-Palacios, A., & Baños, R. M.
Affiliations
  • Universitat Jaume I (ES)
  • Universitat de València (ES)
Corresponding author
Botella, Cristina
Venue
PLoS ONE
Published
2016-02-17
Volume
11
Issue
2
Pages
e0148237
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2274466416
Cited by
124
References
106
Citations by year
2026: 9 · 2025: 12 · 2024: 8 · 2023: 17 · 2022: 16 · 2021: 21 · 2020: 13 · 2019: 13 · 2018: 7 · 2017: 6 · 2016: 2
FWCI
13.25
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
  • Repositori UJI (Universitat Jaume I) (submittedVersion, cc-by-sa)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Ministerio de Economía y Competitividad
  • Instituto de Salud Carlos III
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Physical Sciences › Computer Science › Human-Computer Interaction › Virtual Reality Applications and Impacts
  • Physical Sciences › Computer Science › Computer Vision and Pattern Recognition › Augmented Reality Applications
Keywords
in vivo exposure, specific phobia, virtual reality exposure, exposure therapy, treatment acceptability, treatment satisfaction, single-session intervention, treatment efficacy
MeSH terms
Adult, Aged, Animals, Cockroaches, Female, Follow-Up Studies, Humans, Male, Middle Aged, Phobic Disorders, Spiders, Treatment Outcome, Young Adult, Intention to Treat Analysis, Virtual Reality Exposure Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In Vivo versus Augmented Reality Exposure in the Treatment of Small Animal Phobia: A Randomized Controlled Trial. https://app.cochat.ai/papers/10.1371/journal.pone.0148237
The paper
Botella, C., Pérez-Ara, M. Á., Bretón-López, J., Quero, S., García-Palacios, A., & Baños, R. M. (2016). In Vivo versus Augmented Reality Exposure in the Treatment of Small Animal Phobia: A Randomized Controlled Trial. PLoS ONE. https://doi.org/10.1371/journal.pone.0148237

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.